UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

Nature medicine, 2004-11, Vol.10 (11), p.1240-1244

2004

Volltextzugriff (PDF)

Interstitial Lung Disease in Systemic Sclerosis: A Simple Staging System

American journal of respiratory and critical care medicine, 2008-06, Vol.177 (11), p.1248-1254

2008

Volltextzugriff (PDF)

Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4⁺ memory T lymphocyte populations

European journal of immunology, 2007-11, Vol.37 (11), p.3089-3100

2007

Volltextzugriff (PDF)

A positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment

Journal of medical microbiology, 2019-12, Vol.68 (12), p.1766-1770

2019

Volltextzugriff (PDF)

Late respiratory effects of cancer treatment

Current opinion in supportive & palliative care, 2017-09, Vol.11 (3), p.197-204

2017

Volltextzugriff (PDF)

Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience

Journal of medical microbiology, 2022-07, Vol.71 (7)

2022

Volltextzugriff (PDF)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A

PloS one, 2009-06, Vol.4 (6), p.e5934-e5934

2009

Volltextzugriff (PDF)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A

PloS one, 2011-08, Vol.6 (8), p.e23463-e23463

2011

Volltextzugriff (PDF)

Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A

BMC infectious diseases, 2014-12, Vol.14 (1), p.660-660, Article 660

2014

Volltextzugriff (PDF)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults

Vaccine, 2012-08, Vol.30 (38), p.5616-5624

2012

Volltextzugriff (PDF)

Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis-infected Individuals

American journal of respiratory and critical care medicine, 2009-04, Vol.179 (8), p.724-733

2009

Volltextzugriff (PDF)

Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant ΔureC hly⁺ Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis

Infection and Immunity, 2009-02, Vol.77 (2), p.622-631

2009

Volltextzugriff (PDF)

Respiratory infectious burden in a cohort of antibody deficiency patients treated with immunoglobulin replacement therapy: The impact of lung pathology and gastroesophageal reflux disease

The journal of allergy and clinical immunology. Global, 2023-11, Vol.2 (4), p.100133-100133, Article 100133

2023

Volltextzugriff (PDF)

Investigating the Induction of Vaccine-Induced Th17 and Regulatory T Cells in Healthy, Mycobacterium bovis BCG-Immunized Adults Vaccinated with a New Tuberculosis Vaccine, MVA85A

Clinical and Vaccine Immunology, 2010-07, Vol.17 (7), p.1066-1073

2010

Volltextzugriff (PDF)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials

Tuberculosis (Edinburgh, Scotland), 2005, Vol.85 (1), p.47-52

2005

Volltextzugriff (PDF)

Vaccine Platform for Prevention of Tuberculosis and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 through Breastfeeding

Journal of Virology, 2007-09, Vol.81 (17), p.9408-9418

2007

Volltextzugriff (PDF)

Advances in TB vaccinology

Current respiratory medicine reviews, 2013-01, Vol.9 (3), p.172-180

2013

Volltextzugriff (PDF)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

BMJ open, 2011-01, Vol.1 (2), p.e000223-e000223

2011

Volltextzugriff (PDF)

A comparison of IFNγ detection methods used in tuberculosis vaccine trials

Tuberculosis (Edinburgh, Scotland), 2008-11, Vol.88 (6), p.631-640

2008

Volltextzugriff (PDF)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1

Vaccine, 2008-09, Vol.26 (41), p.5269-5275

2008

Volltextzugriff (PDF)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF- beta 1

Vaccine, 2008-09, Vol.26 (41), p.5269-5275

2008

Volltextzugriff (PDF)

Correction: Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations

European journal of immunology, 2011-05, Vol.41 (5), p.1501-1501

2011

Volltextzugriff (PDF)

ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft- versus -host disease in adults

The European respiratory journal, 2024-03, Vol.63 (3), p.2301727

2024

Volltextzugriff (PDF)

An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome

Pulmonary pharmacology & therapeutics, 2023-04, Vol.79, p.102201-102201, Article 102201

2023

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Englisch
(100)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(51)
Humans
(38)
Adult
(20)
Female
(20)
Middle Aged
(16)
Tuberculosis
(15)
Immunology
(14)
Male
(13)
General & Internal Medicine
(11)
Infectious Diseases
(11)
Mycobacterium Tuberculosis
(11)
Young Adult
(11)
Microbiology
(10)
Adolescent
(9)
Biological And Medical Sciences
(9)
Tuberculosis Vaccines - Immunology
(9)
Medical Sciences
(8)
Mycobacterium Tuberculosis - Immunology
(8)
Respiratory System
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

Interstitial Lung Disease in Systemic Sclerosis: A Simple Staging System

Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4⁺ memory T lymphocyte populations

A positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment

Late respiratory effects of cancer treatment

Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A

Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults

Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis-infected Individuals

Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant ΔureC hly⁺ Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis

Respiratory infectious burden in a cohort of antibody deficiency patients treated with immunoglobulin replacement therapy: The impact of lung pathology and gastroesophageal reflux disease

Investigating the Induction of Vaccine-Induced Th17 and Regulatory T Cells in Healthy, Mycobacterium bovis BCG-Immunized Adults Vaccinated with a New Tuberculosis Vaccine, MVA85A

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials

Vaccine Platform for Prevention of Tuberculosis and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 through Breastfeeding

Advances in TB vaccinology

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

A comparison of IFNγ detection methods used in tuberculosis vaccine trials

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF- beta 1

Correction: Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations

ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft- versus -host disease in adults

An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome

Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1,048 patients hospitalised during the 2016-17 and 2017-18 influenza seasons

Suchergebnisse filtern